Implantable medical device with beneficial agent concentration gradient

• US 8,449,901 B2
• Filed: 03/07/2006
• Issued: 05/28/2013
• Est. Priority Date: 03/28/2003
• Status: Expired due to Fees

• Current Assignee: Innovational Holdings, LLC
• Original Assignee: Innovational Holdings, LLC
• Inventors: Shanley, John F., Parker, Theodore L., Park, Kinam
• Primary Examiner(s): ROGERS, JAMES WILLIAM
• Application Number:
  US11/369,592
• Publication Number:
  US 20060147489A1
• Time in Patent Office: 2,639 Days
• Field of Search: None
• US Class Current: 424/423
• CPC Class Codes: A61L 2300/60 characterised by a special physical form
• CPC Class Codes: A61L 2300/604 Biodegradation
• CPC Class Codes: A61L 31/041 Mixtures of macromolecular compounds
• CPC Class Codes: A61L 31/08 Materials for coatings
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

The implantable medical devices are configured to release at least one therapeutic agent from a matrix affixed to the implantable body with a release profile which is programmable to the agent and treatment. The matrix is formed such that the concentration of the therapeutic agent in the matrix varies as a gradient relative to a surface of the implantable body. The change in the concentration gradient of the agent in the matrix directly controls the rate of elution of the agent from the matrix. The therapeutic agent matrix can be disposed in the stent or on surfaces of the stent in various configurations, including within volumes defined by the stent, such as openings, holes, or concave surfaces, as a reservoir of agent, and alternatively as a coating on all or a portion of the surfaces of the stent structure.

Claims

1. An implantable medical device configured to release at least one therapeutic agent therefrom, the device comprising:

an implantable body having a mural surface and a luminal surface; and

a matrix affixed to the implantable body on said luminal surface, the matrix containing the at least one therapeutic agent therein, wherein the matrix is formed with an outer surface and an implantable body contacting surface such that the concentration of the therapeutic agent in the matrix varies as a gradient relative to the said surfaces of the matrix;

wherein the concentration of the therapeutic agent in the matrix is higher at said luminal surface of the implantable body than at said mural surface of the implantable body;

wherein the implantable body is substantially cylindrical and contains a plurality of struts therein, and the matrix is disposed in a plurality of holes passing through at least some of said struts in the implantable body, and the matrix is coated with a barrier layer at the luminal surface; and

wherein the therapeutic agent has a maximum concentration substantially adjacent to the barrier layer and a minimum concentration substantially adjacent to said mural surface of the implantable body.

2. The device of claim 1, wherein the matrix comprises a bioresorbable polymer.

3. The device of claim 1, wherein the matrix is selected from the group consisting of poly(lactide-co-glycolide)(PLGA) and Poly vinylpyrrolidone (PVP).

4. The device of claim 1, wherein the at least one therapeutic agent comprises a plurality of therapeutic agents.

5. The device of claim 4, wherein the concentration of each of the therapeutic agents in the matrix vary with different continuous concentration gradients relative to the luminal surface of the implantable body.

6. The device of claim 1, wherein the therapeutic agent is selected from the group consisting of antithrombic agents, antiproliferative agents, and antirestenotic agents.

7. The device of claim 1, wherein the therapeutic agent elutes from the matrix at a rate that is controlled by the concentration gradient of the therapeutic agent in the matrix.

8. The device of claim 1, wherein the therapeutic agent is dissolved in the matrix in a solid solution morphology.

9. The device of claim 1, wherein the therapeutic agent is dispersed in the matrix in a solid emulsion morphology.

10. The device of claim 1, wherein the therapeutic also disposed as a coating on the luminal surface of the implantable body.

11. The device of claim 1, wherein the implantable medical device is a stent.